Search
for
Sort by
Research 721–750 of 1000+
- Dermatologic manifestations of endocrine disorders
- Minoxidil for severe hypertension after failure of other hypotensive drugs.
- <i>Polycystic Ovary Syndrome in Adolescence</i>
- Drug Reactions Affecting Hair: Diagnosis
- Prevalence of polycystic ovaries in women with androgenic alopecia
- Androgen excess: Investigations and management
- Intracrinology and The Skin
- Effects of Melatonin Supplementation on Hormonal, Inflammatory, Genetic, and Oxidative Stress Parameters in Women With Polycystic Ovary Syndrome
- Safety of testosterone treatment in postmenopausal women
- Diagnosis of hyperandrogenism: Biochemical criteria
- Androgenetic alopecia in men and women
- Improved Efficacy of Low-Dose Spironolactone and Metformin Combination Than Either Drug Alone in the Management of Women With Polycystic Ovary Syndrome (PCOS): A Six-Month, Open-Label Randomized Study
- Insulin Resistance and Skin Diseases
- PCOS in adolescents
- Physiopathology of polycystic ovary syndrome in endocrinology, metabolism and inflammation
- The SAHA Syndrome
- Specific dermatologic features of the polycystic ovary syndrome and its association with biochemical markers of the metabolic syndrome and hyperandrogenism
- Familial Cortisol Resistance: Differential Diagnostic and Therapeutic Aspects
- Efficacy of myo-inositol in the treatment of cutaneous disorders in young women with polycystic ovary syndrome
- Dienogest
- PHYSIOLOGIC SKIN CHANGES ASSOCIATED WITH PREGNANCY
- How should postmenopausal androgen excess be evaluated?
- Diagnostic criteria for PCOS: Is there a need for a rethink?
- Phenotypic profiling of parents with cryptic nonclassic congenital adrenal hyperplasia: findings in 145 unrelated families
- Anxiety, Depression, and Quality of Life in Women with Polycystic Ovarian Syndrome
- Peroxisome proliferator-activated receptors (PPARs) and PPAR agonists: the ‘future’ in dermatology therapeutics?
- Polycystic ovary syndrome: A review for dermatologists
- Clinical, metabolic, and endocrine parameters in response to metformin and lifestyle intervention in women with polycystic ovary syndrome: A randomized, double-blind, and placebo control trial
- Androgens in women
- Recommendations for treatment of nonclassic congenital adrenal hyperplasia (NCCAH): An update